Estrella Immunopharma (ESLA) Financial Statements

Estrella Immunopharma's market cap is currently $63.82M. The company's EPS TTM is $-0.243; its P/E ratio is -4.57; Estrella Immunopharma is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.